Subscribe
shutterstock_1642888921_kira_yan
Kira Yan / Shutterstock.com
10 August 2020Big PharmaMuireann Bolger

Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

US biotechnology company  Novavax has signed a deal with  Takeda Pharmaceuticals to develop,  manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
A new drug pricing system reform proposal in Japan
17 August 2021   A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.
Biotechnology
Novavax seals COVID-19 vaccine deal with Australia
5 November 2020   Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.
Generics
Second Circuit says Takeda can’t dodge two antitrust suits
26 August 2021   The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Generics
A new drug pricing system reform proposal in Japan
17 August 2021   A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.
Biotechnology
Novavax seals COVID-19 vaccine deal with Australia
5 November 2020   Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.
Generics
Second Circuit says Takeda can’t dodge two antitrust suits
26 August 2021   The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.

More on this story

Generics
A new drug pricing system reform proposal in Japan
17 August 2021   A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.
Biotechnology
Novavax seals COVID-19 vaccine deal with Australia
5 November 2020   Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.
Generics
Second Circuit says Takeda can’t dodge two antitrust suits
26 August 2021   The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug